These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28155963)

  • 21. Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors.
    Mooney CA; Johnson SA; 't Hart P; Quarles van Ufford L; de Haan CA; Moret EE; Martin NI
    J Med Chem; 2014 Apr; 57(7):3154-60. PubMed ID: 24649802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
    Du QS; Wang SQ; Chou KC
    Biochem Biophys Res Commun; 2007 Oct; 362(2):525-31. PubMed ID: 17707775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
    Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
    J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase.
    Stanley M; Martin SR; Birge M; Carbain B; Streicher H
    Org Biomol Chem; 2011 Aug; 9(16):5625-9. PubMed ID: 21720632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Path of Least Resistance: Mechanisms to Reduce Influenza's Sensitivity to Oseltamivir.
    Phillips AM; Shoulders MD
    J Mol Biol; 2016 Feb; 428(3):533-537. PubMed ID: 26748011
    [No Abstract]   [Full Text] [Related]  

  • 27. Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity.
    Ju H; Xiu S; Ding X; Shang M; Jia R; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2020 Feb; 187():111940. PubMed ID: 31835169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles.
    Mohan S; McAtamney S; Haselhorst T; von Itzstein M; Pinto BM
    J Med Chem; 2010 Oct; 53(20):7377-91. PubMed ID: 20873795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
    Rungrotmongkol T; Frecer V; De-Eknamkul W; Hannongbua S; Miertus S
    Antiviral Res; 2009 Apr; 82(1):51-8. PubMed ID: 19428595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
    Singh A; Soliman ME
    Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replication inhibition activity of carbocycles related to oseltamivir on influenza A virus in vitro.
    Niikura M; Bance N; Mohan S; Mario Pinto B
    Antiviral Res; 2011 Jun; 90(3):160-3. PubMed ID: 21443905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes.
    Albohy A; Mohan S; Zheng RB; Pinto BM; Cairo CW
    Bioorg Med Chem; 2011 May; 19(9):2817-22. PubMed ID: 21489803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A.
    Schade D; Kotthaus J; Riebling L; Kotthaus J; Müller-Fielitz H; Raasch W; Koch O; Seidel N; Schmidtke M; Clement B
    J Med Chem; 2014 Feb; 57(3):759-69. PubMed ID: 24422530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient formal synthesis of oseltamivir phosphate (Tamiflu) with inexpensive D-ribose as the starting material.
    Osato H; Jones IL; Chen A; Chai CL
    Org Lett; 2010 Jan; 12(1):60-3. PubMed ID: 19938847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insight into the oseltamivir resistance R292K mutation in H5N1 influenza virus: a molecular docking and molecular dynamics approach.
    Karthick V; Ramanathan K
    Cell Biochem Biophys; 2014 Mar; 68(2):291-9. PubMed ID: 23794010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses.
    Boechat Fda C; Sacramento CQ; Cunha AC; Sagrillo FS; Nogueira CM; Fintelman-Rodrigues N; Santos-Filho O; Riscado CS; Forezi Lda S; Faro LV; Brozeguini L; Marques IP; Ferreira VF; Souza TM; de Souza MC
    Bioorg Med Chem; 2015 Dec; 23(24):7777-84. PubMed ID: 26643220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses.
    Farrukee R; Mosse J; Hurt AC
    Expert Rev Anti Infect Ther; 2013 Nov; 11(11):1135-45. PubMed ID: 24093683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A synthesis of Tamiflu by using a barium-catalyzed asymmetric Diels-Alder-type reaction.
    Yamatsugu K; Yin L; Kamijo S; Kimura Y; Kanai M; Shibasaki M
    Angew Chem Int Ed Engl; 2009; 48(6):1070-6. PubMed ID: 19016287
    [No Abstract]   [Full Text] [Related]  

  • 39. Comment on 'Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)"'.
    Mitrasinovic PM
    Biophys Chem; 2011 Mar; 154(2-3):102. PubMed ID: 21316835
    [No Abstract]   [Full Text] [Related]  

  • 40. Influenza virus susceptibility and resistance to oseltamivir.
    Aoki FY; Boivin G; Roberts N
    Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.